{
    "2020-01-09": [
        [
            {
                "time": "2023-10-01",
                "original_text": "Pfizer Stock Has No Momentum in Its Business or on the Charts",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "momentum",
                        "business",
                        "charts"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Viatris Will Be the New Kid in Generic Drugs. Donâ€™t Expect the Stock to Surge, Analyst Says.",
                "features": {
                    "keywords": [
                        "Viatris",
                        "generic drugs",
                        "surge",
                        "analyst"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Waltham's Amag Pharma replacing CEO, cutting two products",
                "features": {
                    "keywords": [
                        "Amag Pharma",
                        "CEO",
                        "cutting products"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Merck's Keytruda Gets FDA Nod for High-Risk Bladder Cancer",
                "features": {
                    "keywords": [
                        "Merck",
                        "Keytruda",
                        "FDA",
                        "bladder cancer"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "eFFECTOR Enters Into Agreement with Pfizer Inc. to Develop Novel First-in-Class Inhibitors of eIF4E to Treat Multiple Cancer Types",
                "features": {
                    "keywords": [
                        "eFFECTOR",
                        "Pfizer",
                        "agreement",
                        "inhibitors",
                        "cancer"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-10-01",
                "original_text": "Top Picks 2020- Pfizer PFE",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "top picks"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}